TippingPoint Biosciences
Agent30Agent Readiness: 30/100. Below median. Measured by StartupHub.ai. Median 41.Trust66Data Trust: 66/100. Above median. Measured by StartupHub.ai. Median 61.Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
About
TippingPoint Biosciences is a biotechnology company focused on discovering and developing innovative antibody-based therapeutics for cancer. Their approach leverages advanced platform technologies to identify and engineer antibodies with enhanced efficacy and safety profiles. The company aims to address unmet needs in various oncology indications.
Listed competitors
Adicet Bio focuses on gamma delta T cell therapies, whereas TippingPoint Biosciences concentrates on antibody-based therapeutics targeting DNA packaging.
Morphic Holding develops integrin-targeting therapies, while TippingPoint Biosciences' approach is centered on novel antibody engineering for cancer.
Also in this space
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, Genomics
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
Developing engineered biologics to harness the immune system for disease treatment.
Shares Biotech, Drug Discovery
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, Genomics
Developing novel therapeutics by understanding the complex interplay of biological systems.
Shares Biotech, Drug Discovery
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Shares Biotech, Genomics
Key facts
- Website
- tippingpointbiosciences.com
- Headquarters
- Cambridge, Massachusetts, USA
- Founded
- 2021
- Employees
- 7
- Total funding
- $15M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 31 Mar 2026 | Seed | $5M | |
| 1 Jun 2021 | Seed | $10M | Arch Venture Partners |
Tech stack
Detected on tippingpointbiosciences.com, last scanned 4 Jul 2026. Run your own scan
- CDN
- Cloudflare
TippingPoint Biosciences scores 23. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is TippingPoint Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for TippingPoint Biosciences is 66 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has TippingPoint Biosciences raised?
TippingPoint Biosciences has raised a total of $15M in funding. The most recent round on record is Seed.
How many employees does TippingPoint Biosciences have?
TippingPoint Biosciences has approximately 7 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for TippingPoint Biosciences
